speb/financial-data huggingface dataset:
Financial ratios for BH.A — quarterly report dated 2025-06-30
Total revenue: 100619000
Gross profit: 39347000
Operating income: 6222000
Net income: 50931000
Capital expenditures: 2918000
Operating cash flow: 42147000
Depreciation & amortization: 10272000
Net tangible assets: 513042000
Owner earnings: 58285000
Return on net tangible assets (%): 11.360668327349417
Capex to operating income (%): 46.89810350369656
Buffett classification: The Good
Stock price: 1400.36
P/E ratio: 16.749117770729494
Shares outstanding: 211176
Book value: 589286000
P/B ratio: 0.501831747844001
Market cap (USD): 295722423.35999995
Debt to equity: 0.21286438164151192
Current ratio: 1.3822281440592608
Quick ratio: 1.3475616042891019
Effective tax rate (%): 21.767380418420327
Interest coverage ratio: 2.9741873804971317
COGS to revenue (%): 60.89505958119242
SG&A to revenue (%): 22.712410180979738
Free cash flow (dilution-adjusted): 39443000
Buyback yield (%): 0
Retained earnings: 645355000
Inventory turnover: 14.017844886753604
Receivables turnover: 4.772744521392657
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.843670168625558
FCF margin (%): 39.200349834524296
Revenue growth (%): 5.875729994212659
Rule of 40 score: 45.07607982873695
Financial ratios for BH.A — quarterly report dated 2025-09-30
Total revenue: 99738000
Gross profit: 39064000
Operating income: 9096000
Net income: -5291000
Capital expenditures: 5491000
Operating cash flow: 31246000
Depreciation & amortization: 9545000
Net tangible assets: 504040000
Owner earnings: -1237000
Return on net tangible assets (%): -0.24541703039441315
Capex to operating income (%): 60.36719437115215
Buffett classification: The Good
Stock price: 1545
P/E ratio: 26.386325919935302
Shares outstanding: 211176
Book value: 580279000
P/B ratio: 0.5622587065876932
Market cap (USD): 326266920
Debt to equity: 0.5982777250253757
Current ratio: 2.8269795747062116
Quick ratio: 2.7994613878007835
Interest coverage ratio: 3.8921694480102698
COGS to revenue (%): 60.83338346467746
SG&A to revenue (%): 20.476648819908156
Free cash flow (dilution-adjusted): 22300000
Buyback yield (%): 0
Retained earnings: 640064000
Inventory turnover: 15.422979156075241
Receivables turnover: 4.695983803380574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9712366182685592
FCF margin (%): 22.358579478232972
Revenue growth (%): -0.8755801588169233
Rule of 40 score: 21.48299931941605
Financial ratios for BH.A — quarterly report dated 2025-12-31
Total revenue: 99869000
Gross profit: 36476000
Operating income: 3576000
Net income: -49853000
Capital expenditures: 3011000
Operating cash flow: 17771000
Depreciation & amortization: 10705000
Net tangible assets: 447187000
Owner earnings: -42159000
Return on net tangible assets (%): -9.427599639524404
Capex to operating income (%): 84.20022371364652
Buffett classification: The Gruesome
Stock price: 1740.05
Shares outstanding: 211176
Book value: 523429000
P/B ratio: 0.7020184185438713
Market cap (USD): 367456798.8
Debt to equity: 0.6851683800477237
Current ratio: 2.4265264912336932
Quick ratio: 2.402365460431424
Interest coverage ratio: 0.5123209169054441
COGS to revenue (%): 63.47615376142747
SG&A to revenue (%): 22.22411358880133
Free cash flow (dilution-adjusted): 6368000
Buyback yield (%): 0
Retained earnings: 590211000
Inventory turnover: 16.819580790660652
Receivables turnover: 4.289352746639179
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4113238277961048
FCF margin (%): 6.376353022459422
Revenue growth (%): 0.1313441215985883
Rule of 40 score: 6.50769714405801
Financial ratios for BH.A — annual report dated 2025-12-31
Total revenue: 395261000
Gross profit: 149415000
Operating income: 21798000
Net income: -37488000
Capital expenditures: 20979000
Operating cash flow: 106959000
Depreciation & amortization: 40779000
Net tangible assets: 447187000
Owner earnings: -17688000
Return on net tangible assets (%): -3.9553922631919085
Capex to operating income (%): 96.24277456647398
Buffett classification: The Gruesome
Stock price: 1740.05
Shares outstanding: 211176
Book value: 523429000
P/B ratio: 0.7020184185438713
Market cap (USD): 367456798.8
Debt to equity: 0.6851683800477237
Current ratio: 2.4265264912336932
Quick ratio: 2.402365460431424
Interest coverage ratio: 1.5978595513854275
COGS to revenue (%): 62.19839549057459
SG&A to revenue (%): 21.96978705209975
Free cash flow (dilution-adjusted): 76606000
Buyback yield (%): 0
Retained earnings: 590211000
Inventory turnover: 65.22844255770761
Receivables turnover: 16.97637761456857
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.507280983864512
FCF margin (%): 19.3811177930532
Revenue growth (%): 9.153747162495788
Rule of 40 score: 28.53486495554899
Financial ratios for CASTROLIND.NS — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 11111111.11111111
Buffett classification: The Gruesome
Stock price: 1.315061131264275
Shares outstanding: 989122384
Market cap (USD): 1300756401.2618566
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CASTROLIND.NS — annual report dated 2022-12-31
Total revenue: 574577498.7928537
Gross profit: 248352245.2921294
Operating income: 125496137.13182037
Net income: 98400531.1443747
Capital expenditures: 13243602.124577498
Operating cash flow: 110521487.20424914
Depreciation & amortization: 9824963.785610816
Net tangible assets: 227216320.6180589
Owner earnings: 94981892.80540802
Return on net tangible assets (%): 41.802407743882355
Capex to operating income (%): 10.552995834976578
Buffett classification: The Great
Stock price: 1.250603573153066
P/E ratio: 12.571070230313438
Shares outstanding: 989122384
Book value: 227671414.77547076
P/B ratio: 5.433268769977148
Market cap (USD): 1236999987.716079
Debt to equity: 0.026484202266135747
Current ratio: 1.9960593686054093
Quick ratio: 1.518501309075962
Effective tax rate (%): 25.403797757950127
Interest coverage ratio: 259.25436408977555
COGS to revenue (%): 56.77654523299298
SG&A to revenue (%): 12.92155132568595
Free cash flow (dilution-adjusted): 94890149.68614195
Buyback yield (%): 0
Retained earnings: 158899082.56880733
Inventory turnover: 5.056601302297732
Receivables turnover: 13.585454960611944
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 53.31606749064055
FCF margin (%): 16.51476952813143
Rule of 40 score: 16.51476952813143
Financial ratios for CASTROLIND.NS — annual report dated 2023-12-31
Total revenue: 614077764.2770352
Gross profit: 266543134.872418
Operating income: 134782503.03766707
Net income: 104997569.86634265
Capital expenditures: 11130012.150668288
Operating cash flow: 103650060.75334144
Depreciation & amortization: 11230862.69744836
Net tangible assets: 257533414.33778858
Owner earnings: 105098420.41312271
Return on net tangible assets (%): 40.809624911535735
Capex to operating income (%): 8.257757423868165
Buffett classification: The Great
Stock price: 1.9295261239368167
P/E ratio: 18.17696811581591
Shares outstanding: 989122384
Book value: 257799513.9732685
P/B ratio: 7.4031849412119595
Market cap (USD): 1908537479.6986635
Debt to equity: 0.036268257851052706
Current ratio: 1.9119166721516487
Quick ratio: 1.4734581715263608
Effective tax rate (%): 26.836847007027348
Interest coverage ratio: 147.3120849933599
COGS to revenue (%): 56.59456336344893
SG&A to revenue (%): 13.0250936907631
Free cash flow (dilution-adjusted): 89924665.85662211
Buyback yield (%): 0
Retained earnings: 186459295.26123938
Inventory turnover: 5.367053216242588
Receivables turnover: 11.952745849297573
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 50.31821419013014
FCF margin (%): 14.643856379084502
Revenue growth (%): 6.874662785641409
Rule of 40 score: 21.51851916472591
Financial ratios for CASTROLIND.NS — annual report dated 2024-12-31
Total revenue: 623112250.8450868
Gross profit: 277307378.4823406
Operating income: 137734001.63189182
Net income: 108081361.46404009
Capital expenditures: 10805455.181256555
Operating cash flow: 121704161.32416365
Depreciation & amortization: 11629560.55484322
Net tangible assets: 265398065.04254574
Owner earnings: 108905466.83762676
Return on net tangible assets (%): 41.034762940026795
Capex to operating income (%): 7.845161727120393
Buffett classification: The Great
Stock price: 2.1114348991723975
P/E ratio: 19.323105231470077
Shares outstanding: 989122384
Book value: 265575241.86968178
P/B ratio: 7.863939072133147
Market cap (USD): 2088467521.1302013
Debt to equity: 0.03599942063843888
Current ratio: 2.0175873660675627
Quick ratio: 1.6048983255001066
Effective tax rate (%): 26.270465406604586
Interest coverage ratio: 125.97228144989339
COGS to revenue (%): 55.49640083207375
SG&A to revenue (%): 13.879805749689467
Free cash flow (dilution-adjusted): 108328476.51241404
Buyback yield (%): 0
Retained earnings: 194566965.8468353
Inventory turnover: 5.659296846683581
Receivables turnover: 12.213393040736594
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 49.96152317488774
FCF margin (%): 17.38506607204322
Revenue growth (%): 1.4712284165976992
Rule of 40 score: 18.85629448864092
Financial ratios for CASTROLIND.NS — quarterly report dated 2024-12-31
Total revenue: 157814430.58631542
Gross profit: 79545401.5619536
Operating income: 40848583.75101993
Net income: 31634223.102925748
Capital expenditures: 0
Net tangible assets: 265398065.04254574
Owner earnings: 31634223.102925748
Return on net tangible assets (%): 11.919537958143927
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.1114348991723975
P/E ratio: 16.504811216124395
Shares outstanding: 989122384
Book value: 265575241.86968178
P/B ratio: 7.863939072133147
Market cap (USD): 2088467521.1302013
Debt to equity: 0.03599942063843888
Current ratio: 2.0175873660675627
Quick ratio: 1.6048983255001066
Effective tax rate (%): 26.835251934327232
Interest coverage ratio: 130.76119402985074
COGS to revenue (%): 49.59560968764079
Buyback yield (%): 0
Retained earnings: 194566965.8468353
Inventory turnover: 1.280917952728868
Receivables turnover: 3.093262354634559
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.817383068505663
Rule of 40 score: 0
Financial ratios for CASTROLIND.NS — quarterly report dated 2025-03-31
Total revenue: 166238017.30184707
Gross profit: 77008417.11480008
Operating income: 33061725.508534018
Net income: 27292494.739303246
Capital expenditures: 0
Owner earnings: 27292494.739303246
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.2643248920527483
P/E ratio: 20.51566242634856
Shares outstanding: 989122384
Market cap (USD): 2239694435.377757
Effective tax rate (%): 25.34535686876439
Interest coverage ratio: 121.37768240343348
COGS to revenue (%): 53.675808720112514
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.337653017050573
Rule of 40 score: 5.337653017050573
Financial ratios for CASTROLIND.NS — quarterly report dated 2025-06-30
Total revenue: 175149777.6737655
Gross profit: 81721273.11022702
Operating income: 37783758.483501054
Net income: 28551369.061549265
Capital expenditures: 0
Net tangible assets: 212673765.50432953
Owner earnings: 28551369.061549265
Return on net tangible assets (%): 13.424960522913215
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.480458694125907
P/E ratio: 21.483008500032785
Shares outstanding: 989122384
Book value: 212834074.4207817
P/B ratio: 11.52765234431738
Market cap (USD): 2453477216.947344
Debt to equity: 0.0402170566502463
Current ratio: 1.6013334690553744
Quick ratio: 1.156322708236389
Effective tax rate (%): 25.957395156885354
Interest coverage ratio: 123.24427480916029
COGS to revenue (%): 53.3420628929137
Buyback yield (%): 0
Inventory turnover: 1.3045339433052854
Receivables turnover: 2.6627826303524094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.02035695836891
Revenue growth (%): 5.360843756778505
Rule of 40 score: 5.360843756778505
Financial ratios for CASTROLIND.NS — annual report dated 2025-12-31
Total revenue: 634991645.3158071
Gross profit: 282743678.2889607
Operating income: 139143366.3807508
Net income: 105818202.07196169
Capital expenditures: 10499053.135791468
Operating cash flow: 121437005.68118526
Depreciation & amortization: 11230923.471092794
Net tangible assets: 211585162.08087334
Owner earnings: 106550072.40726301
Return on net tangible assets (%): 50.3580077919343
Capex to operating income (%): 7.545493118990626
Buffett classification: The Great
Stock price: 2.084772195611006
P/E ratio: 19.48714685983178
Shares outstanding: 989122384
Book value: 211685418.29118863
P/B ratio: 9.741317379655843
Market cap (USD): 2062094844.2196727
Debt to equity: 0.03305267589328
Current ratio: 1.664983702946252
Quick ratio: 1.2770215092705028
Effective tax rate (%): 25.920409261411052
Interest coverage ratio: 134.45532831001074
COGS to revenue (%): 55.47285064698122
SG&A to revenue (%): 14.791099447048586
Free cash flow (dilution-adjusted): 110338643.19928707
Buyback yield (%): 0
Retained earnings: 143569121.0872229
Inventory turnover: 5.787842735293041
Receivables turnover: 12.04606834175102
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 62.87513465081393
FCF margin (%): 17.376392904258005
Revenue growth (%): 1.9064613887159236
Rule of 40 score: 19.28285429297393
Financial ratios for CASTROLIND.NS — quarterly report dated 2025-12-31
Total revenue: 160401024.841261
Gross profit: 76907652.89072074
Operating income: 38248858.1931603
Net income: 27255207.75314693
Capital expenditures: 0
Net tangible assets: 211585162.08087334
Owner earnings: 27255207.75314693
Return on net tangible assets (%): 12.881436243024114
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.084772195611006
P/E ratio: 17.972941946674993
Shares outstanding: 989122384
Book value: 211685418.29118863
P/B ratio: 9.741317379655843
Market cap (USD): 2062094844.2196727
Debt to equity: 0.03305267589328
Current ratio: 1.664983702946252
Quick ratio: 1.2770215092705028
Effective tax rate (%): 26.34415076163526
Interest coverage ratio: 150.5964912280702
COGS to revenue (%): 52.05289182732374
Buyback yield (%): 0
Retained earnings: 143569121.0872229
Inventory turnover: 1.3718929604275727
Receivables turnover: 3.042877369455421
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.283627467759306
Revenue growth (%): -8.42065175782043
Rule of 40 score: -8.42065175782043
Financial ratios for CF.TO — annual report dated 2022-03-31
Total revenue: 1636801600
Gross profit: 555995200
Operating income: 340565600
Net income: 216452000
Capital expenditures: 9697600
Operating cash flow: 210602400
Depreciation & amortization: 41189600
Net tangible assets: 384637600
Owner earnings: 247944000
Return on net tangible assets (%): 64.46171669124391
Capex to operating income (%): 2.8474983967846432
Buffett classification: The Great
Stock price: 8.431999999999999
P/E ratio: 3.9150035989133842
Shares outstanding: 100499331
Book value: 1133415200
P/B ratio: 0.7476610151266719
Market cap (USD): 847410358.9919999
Debt to equity: 0.2012247585880267
Current ratio: 1.144803378057646
Quick ratio: 1.144803378057646
Effective tax rate (%): 28.472859261530814
Interest coverage ratio: 18.039961013645225
COGS to revenue (%): 66.03160700722678
R&D to revenue (%): 1.0958933568979894
SG&A to revenue (%): 8.568124566838156
Free cash flow (dilution-adjusted): 81410400
Buyback yield (%): 19.460512637131554
Retained earnings: 201232000
Receivables turnover: 0.698657833855505
Capitalized R&D asset: 17937600
ROCI (R&D-adjusted, %): 24.66015375136199
FCF margin (%): 4.973748803764611
Rule of 40 score: 4.973748803764611
Financial ratios for CF.TO — annual report dated 2023-03-31
Total revenue: 1118812592.5925925
Gross profit: 353660740.7407407
Operating income: 94434074.07407407
Net income: -40549629.62962963
Capital expenditures: 18035555.555555556
Operating cash flow: -432900740.7407407
Depreciation & amortization: 50347407.4074074
Net tangible assets: 93262222.22222221
Owner earnings: -8237777.77777778
Return on net tangible assets (%): -8.832920320244
Capex to operating income (%): 19.098567685863546
Buffett classification: The Great
Stock price: 7.192592592592593
Shares outstanding: 100499331
Book value: 1036027407.4074068
P/B ratio: 0.6977139200593154
Market cap (USD): 722850743.7111112
Debt to equity: 0.3102020038079932
Current ratio: 1.1717879217142972
Quick ratio: 1.1717879217142972
Interest coverage ratio: 2.3375199398595505
COGS to revenue (%): 68.38963530780319
R&D to revenue (%): 2.387319360406569
SG&A to revenue (%): 14.826764089176555
Free cash flow (dilution-adjusted): -497974074.0740741
Buyback yield (%): 7.792910445371826
Retained earnings: 88557037.03703703
Receivables turnover: 0.4940204889386486
Capitalized R&D asset: 38727821.62962963
ROCI (R&D-adjusted, %): 7.203860452264292
Rosenberg metric: -11.279906969675947
FCF margin (%): -44.50915885028904
Revenue growth (%): -31.6464137991683
Rule of 40 score: -76.15557264945734
Financial ratios for CF.TO — annual report dated 2024-03-31
Total revenue: 1095411111.111111
Gross profit: 396776296.2962963
Operating income: 130417037.03703703
Net income: 22060740.74074074
Capital expenditures: 17559259.259259257
Operating cash flow: -9542962.962962963
Depreciation & amortization: 50418518.518518515
Net tangible assets: 68002222.22222222
Owner earnings: 54920000
Return on net tangible assets (%): 80.76206659913075
Capex to operating income (%): 13.463930524868939
Buffett classification: The Great
Stock price: 6.066176470588235
P/E ratio: 27.634914175669177
Shares outstanding: 100499331
Book value: 1007489629.6296291
P/B ratio: 0.6051145928382167
Market cap (USD): 609646677.0220587
Debt to equity: 0.444632827761852
Current ratio: 1.2112012236772434
Quick ratio: 1.2112012236772434
Effective tax rate (%): 47.81222072300979
Interest coverage ratio: 1.899748589186098
COGS to revenue (%): 63.77832100919324
R&D to revenue (%): 3.365149563329851
SG&A to revenue (%): 14.816760830535468
Free cash flow (dilution-adjusted): -29274814.814814813
Buyback yield (%): 3.6591929373119463
Retained earnings: 43368888.88888889
Receivables turnover: 0.46342632853080123
Capitalized R&D asset: 60677082.07407407
ROCI (R&D-adjusted, %): 8.689604067389105
Rosenberg metric: 1.6142326252149326
FCF margin (%): -2.672495697539568
Revenue growth (%): -2.091635510398928
Rule of 40 score: -4.764131207938496
Financial ratios for CF.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.303703703703703
Shares outstanding: 100499331
Market cap (USD): 633518005.0444443
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CF.TO — quarterly report dated 2024-12-31
Total revenue: 315408391.60839164
Gross profit: 117988111.88811189
Operating income: 31620979.02097902
Net income: -8113986.013986015
Capital expenditures: 588111.8881118881
Operating cash flow: 64793006.993007
Depreciation & amortization: 13667832.167832168
Net tangible assets: -8709790.20979021
Owner earnings: 4965734.265734265
Capex to operating income (%): 1.8598788093237204
Buffett classification: The Great
Stock price: 6.741258741258742
Shares outstanding: 100499331
Book value: 945009790.2097902
P/B ratio: 0.7169153172942301
Market cap (USD): 677491993.5944057
Debt to equity: 0.8414846037041093
Current ratio: 1.2345977936720496
Quick ratio: 1.2345977936720496
Interest coverage ratio: 1.273423639077417
COGS to revenue (%): 62.59195537365253
R&D to revenue (%): 3.082916143794038
SG&A to revenue (%): 18.734064394258525
Free cash flow (dilution-adjusted): 61003496.503496505
Buyback yield (%): 0
Retained earnings: -26178321.67832168
Receivables turnover: 0.22259675319483696
Capitalized R&D asset: 9723776.223776225
ROCI (R&D-adjusted, %): 2.4607569600565062
FCF margin (%): 19.341113973669387
Rule of 40 score: 19.341113973669387
Financial ratios for CF.TO — annual report dated 2025-03-31
Total revenue: 1237106293.7062938
Gross profit: 443417482.5174825
Operating income: 144120279.72027972
Net income: 17588111.88811189
Capital expenditures: 53500000
Operating cash flow: 332595804.19580424
Depreciation & amortization: 52413986.013986014
Net tangible assets: -51158741.25874126
Owner earnings: 16502097.90209791
Return on net tangible assets (%): -32.25665349863993
Capex to operating income (%): 37.12177085961609
Buffett classification: The Good
Stock price: 5.664335664335664
P/E ratio: 32.366290847282414
Shares outstanding: 100499331
Book value: 953646853.1468534
P/B ratio: 0.5969316030842219
Market cap (USD): 569261944.8251748
Debt to equity: 0.5652449375419348
Current ratio: 1.1901929112452279
Quick ratio: 1.1901929112452279
Effective tax rate (%): 53.000205557528076
Interest coverage ratio: 1.5614213197969542
COGS to revenue (%): 64.15688087811506
R&D to revenue (%): 3.335044221174837
SG&A to revenue (%): 15.279000962091773
Free cash flow (dilution-adjusted): 267396503.4965035
Buyback yield (%): 2.189192141776669
Retained earnings: -26296503.4965035
Receivables turnover: 0.5777830760236592
Capitalized R&D asset: 74769908.62470862
ROCI (R&D-adjusted, %): 8.900206561232759
Rosenberg metric: 1.2652841692508923
FCF margin (%): 21.614674895509598
Revenue growth (%): 12.935342827722177
Rule of 40 score: 34.550017723231775
Financial ratios for CF.TO — quarterly report dated 2025-03-31
Total revenue: 322536363.6363636
Gross profit: 110360139.86013986
Operating income: 31281818.181818184
Net income: 7599300.6993007
Capital expenditures: 4658741.258741259
Operating cash flow: -11572727.272727273
Depreciation & amortization: 12643356.643356644
Net tangible assets: -51158741.25874126
Owner earnings: 15583916.083916083
Return on net tangible assets (%): -30.461883346774744
Capex to operating income (%): 14.892808441195537
Buffett classification: The Great
Stock price: 5.664335664335664
P/E ratio: 18.72744504232999
Shares outstanding: 100499331
Book value: 953646853.1468534
P/B ratio: 0.5969316030842219
Market cap (USD): 569261944.8251748
Debt to equity: 0.5652449375419348
Current ratio: 1.1901929112452279
Quick ratio: 1.1901929112452279
Effective tax rate (%): 40.56227096209594
Interest coverage ratio: 1.4389153371075656
COGS to revenue (%): 65.78365967300267
R&D to revenue (%): 3.6532987010734415
SG&A to revenue (%): 15.533782714368414
Free cash flow (dilution-adjusted): -24970629.37062937
Buyback yield (%): 0.17677164536314607
Retained earnings: -26296503.4965035
Receivables turnover: 0.15063867450952212
Capitalized R&D asset: 18298146.853146855
ROCI (R&D-adjusted, %): 2.1971289382778965
Rosenberg metric: -0.7844660194174756
FCF margin (%): -7.741957864565604
Revenue growth (%): 2.259918321013479
Rule of 40 score: -5.482039543552125
Financial ratios for CF.TO — quarterly report dated 2025-06-30
Total revenue: 327333576.6423357
Gross profit: 111960583.94160584
Operating income: 33321167.883211676
Net income: -12295620.437956203
Capital expenditures: 843065.6934306569
Operating cash flow: 78465693.43065692
Depreciation & amortization: 14178102.189781021
Net tangible assets: -93240875.91240875
Owner earnings: 1039416.0583941616
Capex to operating income (%): 2.5301204819277108
Buffett classification: The Great
Stock price: 7.350364963503649
Shares outstanding: 100499331
Book value: 947719708.0291972
P/B ratio: 0.779457001030518
Market cap (USD): 738706761.4379562
Debt to equity: 1.141355816804993
Current ratio: 1.1821465500377275
Quick ratio: 1.1821465500377275
Interest coverage ratio: 1.3695136951369515
COGS to revenue (%): 65.79618104257582
R&D to revenue (%): 4.429508949775559
SG&A to revenue (%): 13.86183874571577
Free cash flow (dilution-adjusted): 70407299.27007298
Buyback yield (%): 0
Retained earnings: -78905839.41605839
Receivables turnover: 0.14150579327236348
Capitalized R&D asset: 25602871.4715941
ROCI (R&D-adjusted, %): 2.112259266628048
Rosenberg metric: 0.1358240377742637
FCF margin (%): 21.509342241112105
Revenue growth (%): 1.4873402030974088
Rule of 40 score: 22.99668244420951
Financial ratios for CF.TO — quarterly report dated 2025-09-30
Total revenue: 385461151.0791367
Gross profit: 133934532.37410073
Operating income: 2592086.330935252
Net income: -134395683.4532374
Capital expenditures: 1341726.6187050361
Operating cash flow: 58779136.69064748
Depreciation & amortization: 13530215.827338131
Net tangible assets: -154124460.4316547
Owner earnings: -122207194.24460432
Capex to operating income (%): 51.76242020538441
Buffett classification: The Good
Stock price: 7.575539568345324
Shares outstanding: 100499331
Book value: 796876978.4172659
P/B ratio: 0.9554004936808173
Market cap (USD): 761336658.5827339
Debt to equity: 1.487677164181396
Current ratio: 1.1548378722030228
Quick ratio: 1.1548378722030228
Interest coverage ratio: 0.1046379926233555
COGS to revenue (%): 65.25342904229447
R&D to revenue (%): 3.749596391130123
SG&A to revenue (%): 25.75313881718805
Free cash flow (dilution-adjusted): 50418705.035971224
Buyback yield (%): 0
Retained earnings: -231716546.76258993
Receivables turnover: 0.14805641602396355
Capitalized R&D asset: 28056209.89743859
ROCI (R&D-adjusted, %): 0.2226139081418717
Rosenberg metric: 1.5155210104972818
FCF margin (%): 13.080100262975675
Revenue growth (%): 17.757901597829264
Rule of 40 score: 30.838001860804937
Financial ratios for CF.TO — quarterly report dated 2025-12-31
Total revenue: 465591970.8029197
Gross profit: 168366423.35766423
Operating income: 80678832.11678831
Net income: 28191970.802919704
Capital expenditures: 1170072.9927007298
Operating cash flow: 271309489.0510949
Depreciation & amortization: 15362043.795620436
Net tangible assets: -166226277.37226275
Owner earnings: 42383941.60583941
Return on net tangible assets (%): -25.497738550037326
Capex to operating income (%): 1.4502849905003166
Buffett classification: The Great
Stock price: 7.970802919708029
P/E ratio: 7.103621511275665
Shares outstanding: 100499331
Book value: 814115328.4671531
P/B ratio: 0.9839642283505091
Market cap (USD): 801060360.9635036
Debt to equity: 1.2495566366428834
Current ratio: 1.19055342051499
Quick ratio: 1.19055342051499
Effective tax rate (%): 39.85548997928897
Interest coverage ratio: 3.5917850063367234
COGS to revenue (%): 63.838202994069235
R&D to revenue (%): 3.647659913366705
SG&A to revenue (%): 10.902061734453119
Free cash flow (dilution-adjusted): 261418978.10218978
Buyback yield (%): 0.2093028712280536
Retained earnings: -228925547.44525546
Receivables turnover: 0.24694168854331888
Capitalized R&D asset: 31451639.867667906
ROCI (R&D-adjusted, %): 5.099419100876947
Rosenberg metric: 2.3822960909483952
FCF margin (%): 56.14765599401751
Revenue growth (%): 20.788299806465265
Rule of 40 score: 76.93595580048277
Financial ratios for CHAI — quarterly report dated 2024-09-30
Total revenue: 5862575
Gross profit: 1703033
Operating income: -3794957
Net income: -626322
Capital expenditures: 0
Depreciation & amortization: 424393
Owner earnings: -201929
Buffett classification: The Gruesome
Stock price: 36.8
Shares outstanding: 21891846
Market cap (USD): 805619932.8
Interest coverage ratio: -7.187935874172762
COGS to revenue (%): 70.95858048724324
R&D to revenue (%): 5.027705402489521
SG&A to revenue (%): 81.51441985816813
Buyback yield (%): 0
Capitalized R&D asset: 294753
ROCI (R&D-adjusted, %): -1220.8374469471048
Rule of 40 score: 0
Financial ratios for CHAI — annual report dated 2024-12-31
Total revenue: 34829376
Gross profit: 1487521
Operating income: -362943
Net income: -372320
Capital expenditures: 2435
Operating cash flow: -52905
Depreciation & amortization: 925
Net tangible assets: 2179084
Owner earnings: -373830
Return on net tangible assets (%): -17.155373542277395
Buffett classification: The Gruesome
Stock price: 24.32
Shares outstanding: 21891846
Book value: 2180594
P/B ratio: 244.15810312236025
Market cap (USD): 532409694.72
Debt to equity: 0
Current ratio: 1.1249810298842844
Quick ratio: 1.1249810298842844
COGS to revenue (%): 95.72911957997755
R&D to revenue (%): 0
SG&A to revenue (%): 1.5104548528230881
Free cash flow (dilution-adjusted): -55340
Buyback yield (%): 0
Retained earnings: -372320
Receivables turnover: 2.6454122504149717
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.64422629797202
FCF margin (%): -0.1588888643884978
Rule of 40 score: -0.1588888643884978
Financial ratios for CHAI — quarterly report dated 2024-12-31
Total revenue: 24717954
Gross profit: -1275743
Operating income: 9769456
Net income: 15975149
Capital expenditures: 0
Operating cash flow: 14479502
Depreciation & amortization: -1261255
Net tangible assets: 2179084
Owner earnings: 14713894
Return on net tangible assets (%): 675.2329878058854
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.32
P/E ratio: 8.331842393457489
Shares outstanding: 21891846
Book value: 2180594
P/B ratio: 244.15810312236025
Market cap (USD): 532409694.72
Debt to equity: 0
Current ratio: 1.1249810298842844
Quick ratio: 1.1249810298842844
COGS to revenue (%): 105.16183904217962
R&D to revenue (%): -1.3340626817251946
SG&A to revenue (%): -12.42177244928929
Free cash flow (dilution-adjusted): 15637212
Buyback yield (%): 0
Retained earnings: -372320
Receivables turnover: 1.8774145800600548
Capitalized R&D asset: -132268.49
ROCI (R&D-adjusted, %): 461.41932132001153
Rosenberg metric: -10.106007402808453
FCF margin (%): 63.26256614928566
Revenue growth (%): 321.62281932427305
Rule of 40 score: 384.8853854735587
Financial ratios for CHAI — quarterly report dated 2025-03-31
Total revenue: 14509763
Gross profit: -228342
Operating income: -58063
Net income: -100257
Capital expenditures: 0
Operating cash flow: 211393
Depreciation & amortization: 344
Owner earnings: -99913
Buffett classification: The Gruesome
Stock price: 8.56
Shares outstanding: 21891846
Market cap (USD): 187394201.76000002
COGS to revenue (%): 101.57371281667385
R&D to revenue (%): 0.4278912067688494
SG&A to revenue (%): 0.942448198499176
Free cash flow (dilution-adjusted): 211393
Buyback yield (%): 0
Capitalized R&D asset: -61580.020000000004
FCF margin (%): 1.4569018115595684
Revenue growth (%): -41.29868920380708
Rule of 40 score: -39.84178739224751
Financial ratios for CHAI — quarterly report dated 2025-09-30
Total revenue: 3686179
Gross profit: 740413
Operating income: -4793200
Net income: -5370479
Capital expenditures: 0
Depreciation & amortization: 402787
Net tangible assets: 5371442
Owner earnings: -4967692
Return on net tangible assets (%): -92.48339645108334
Buffett classification: The Gruesome
Stock price: 9.28
P/E ratio: 20.566355470910317
Shares outstanding: 21891846
Book value: 15438987
P/B ratio: 13.15865677456688
Market cap (USD): 203156330.88
Debt to equity: 0.13944580690430014
Current ratio: 2.0213152787550874
Quick ratio: 1.4774609079085044
Interest coverage ratio: -36.23772406649984
COGS to revenue (%): 79.92015580361127
R&D to revenue (%): 34.14988800055559
SG&A to revenue (%): 105.04101944045583
Buyback yield (%): 0
Retained earnings: -128989459
Inventory turnover: 1.1674322078932842
Receivables turnover: 1.3429735400426044
Capitalized R&D asset: 1191605.1300000001
ROCI (R&D-adjusted, %): -23.059650533371993
Rosenberg metric: 15.603437167799504
Revenue growth (%): -74.59518118938261
Rule of 40 score: -74.59518118938261
Financial ratios for CHAI — annual report dated 2025-12-31
Total revenue: 55239839
Gross profit: -302662
Operating income: -7041446
Net income: -31591331
Capital expenditures: 0
Operating cash flow: -6651267
Depreciation & amortization: 1033
Net tangible assets: 3101182
Owner earnings: -31590298
Return on net tangible assets (%): -1018.6534682582318
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 21891846
Book value: 3101659
P/B ratio: 11.504716985329463
Market cap (USD): 35683708.98
Debt to equity: 0.05242678192541475
Current ratio: 1.24416472519031
Quick ratio: 1.24416472519031
Interest coverage ratio: -450.88339629890504
COGS to revenue (%): 100.54790528987603
R&D to revenue (%): 0.5892721736571318
SG&A to revenue (%): 11.306466696979331
Free cash flow (dilution-adjusted): -6651267
Buyback yield (%): 0
Retained earnings: -31963651
Receivables turnover: 5.777460142050211
Capitalized R&D asset: 325513
ROCI (R&D-adjusted, %): -199.12155595859718
FCF margin (%): -12.040706708069877
Revenue growth (%): 58.60128817696878
Rule of 40 score: 46.5605814688989
Financial ratios for CHAI — quarterly report dated 2025-12-31
Total revenue: 47050550
Gross profit: -1870639
Operating income: 3905342
Net income: -18623043
Capital expenditures: 0
Operating cash flow: 7699198
Depreciation & amortization: -1233556
Net tangible assets: 3101182
Owner earnings: -19856599
Return on net tangible assets (%): -640.2913147309639
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.63
Shares outstanding: 21891846
Book value: 3101659
P/B ratio: 11.504716985329463
Market cap (USD): 35683708.98
Debt to equity: 0.05242678192541475
Current ratio: 1.24416472519031
Quick ratio: 1.24416472519031
COGS to revenue (%): 103.9764699881298
R&D to revenue (%): -2.6884127815721603
SG&A to revenue (%): 2.8892754707437
Free cash flow (dilution-adjusted): 10462103
Buyback yield (%): 0
Retained earnings: -31963651
Receivables turnover: 4.920953467777858
Capitalized R&D asset: -401011.19999999995
ROCI (R&D-adjusted, %): 97.07543468763232
Rosenberg metric: -2.0741961160636975
FCF margin (%): 22.235878220339615
Revenue growth (%): 1176.4043742856763
Rule of 40 score: 1198.640252506016
Financial ratios for CHER.V — quarterly report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7391304347826088
Shares outstanding: 19629070
Market cap (USD): 14508443.043478262
Buyback yield (%): 0
Capitalized R&D asset: 15446.422288855576
Rule of 40 score: 0
Financial ratios for CHER.V — quarterly report dated 2025-10-31
Total revenue: 279955.7142857143
Gross profit: 162957.85714285716
Operating income: -351681.4285714286
Net income: -391035.7142857143
Capital expenditures: 43685
Operating cash flow: -384882.85714285716
Depreciation & amortization: 35542.14285714286
Net tangible assets: 535066.4285714286
Owner earnings: -399178.5714285715
Return on net tangible assets (%): -74.60355389784714
Buffett classification: The Gruesome
Stock price: 0.6571428571428573
Shares outstanding: 19629070
Book value: 550472.142857143
P/B ratio: 23.432799116602503
Market cap (USD): 12899103.142857146
Debt to equity: 0.6515562614430989
Current ratio: 1.9959749479051014
Quick ratio: 1.2860531120702112
Interest coverage ratio: -14.280236672660827
COGS to revenue (%): 41.79181401139976
R&D to revenue (%): 42.386040649286365
SG&A to revenue (%): 112.09834208471747
Free cash flow (dilution-adjusted): -428567.85714285716
Buyback yield (%): 0
Retained earnings: -4646120
Inventory turnover: 0.22372619294775833
Receivables turnover: 0.9263790340498149
Capitalized R&D asset: 124233.88198757765
ROCI (R&D-adjusted, %): -27.641934922196626
FCF margin (%): -153.08416127040502
Rule of 40 score: -153.08416127040502
Financial ratios for CMMB — annual report dated 2021-12-31
Capital expenditures: 77096.77419354838
Buffett classification: The Gruesome
Stock price: 27.6
Shares outstanding: 7327660
Market cap (USD): 202243416
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMMB — annual report dated 2022-12-31
Total revenue: 0
Operating income: -8105965.909090909
Net income: -7853977.2727272725
Capital expenditures: 19318.18181818182
Operating cash flow: -5786931.818181818
Depreciation & amortization: 16477.272727272728
Net tangible assets: 10286647.727272727
Owner earnings: -7856818.181818182
Return on net tangible assets (%): -76.37880085061725
Buffett classification: The Gruesome
Stock price: 12.8
Shares outstanding: 7327660
Book value: 10290625
P/B ratio: 9.114514230185241
Market cap (USD): 93794048
Debt to equity: 0.005907848604477818
Current ratio: 6.184027263298266
Quick ratio: 6.184027263298266
Free cash flow (dilution-adjusted): -6718465.909090909
Buyback yield (%): 0.3689175748899624
Retained earnings: -18130397.727272727
Receivables turnover: 0
Capitalized R&D asset: 4823011.363636363
ROCI (R&D-adjusted, %): -32.303766114353266
Rule of 40 score: 0
Financial ratios for CMMB — annual report dated 2023-12-31
Total revenue: 0
Operating income: -7032872.928176795
Net income: -6690883.977900553
Capital expenditures: 828.7292817679557
Operating cash flow: -6522375.690607735
Depreciation & amortization: 18508.28729281768
Net tangible assets: 4693088.397790055
Owner earnings: -6673204.419889503
Return on net tangible assets (%): -142.19217398572488
Buffett classification: The Gruesome
Stock price: 2.04
Shares outstanding: 7327660
Book value: 4695303.867403315
P/B ratio: 3.183697332941107
Market cap (USD): 14948426.4
Debt to equity: 0.023062893451785606
Current ratio: 4.319346837536172
Quick ratio: 4.319346837536172
Free cash flow (dilution-adjusted): -6935082.872928176
Buyback yield (%): 0
Retained earnings: -24496685.082872927
Receivables turnover: 0
Capitalized R&D asset: 8309041.923028629
ROCI (R&D-adjusted, %): -40.14364180919125
Rule of 40 score: 0
Financial ratios for CMMB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.28
Shares outstanding: 7327660
Market cap (USD): 46017704.800000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMMB — annual report dated 2024-12-31
Total revenue: 0
Operating income: -4038082.191780822
Net income: -3820547.9452054794
Capital expenditures: 0
Operating cash flow: -4215342.465753425
Depreciation & amortization: 14520.54794520548
Net tangible assets: 3704931.506849315
Owner earnings: -3806027.397260274
Return on net tangible assets (%): -102.72868446350662
Buffett classification: The Gruesome
Stock price: 7.24
Shares outstanding: 7327660
Book value: 3708767.1232876712
P/B ratio: 14.304553679544952
Market cap (USD): 53052258.4
Debt to equity: 0.023934402009307822
Current ratio: 4.984462399005593
Quick ratio: 4.984462399005593
Free cash flow (dilution-adjusted): -4384383.561643836
Buyback yield (%): 0
Retained earnings: -28115890.410958905
Receivables turnover: 0
Capitalized R&D asset: 8096889.708525695
ROCI (R&D-adjusted, %): -44.419391860469865
Rule of 40 score: 0
Financial ratios for CMMB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.24
Shares outstanding: 7327660
Market cap (USD): 53052258.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMMB — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -944986.4498644987
Net income: -900542.0054200542
Capital expenditures: 0
Net tangible assets: 2816531.165311653
Owner earnings: -900542.0054200542
Return on net tangible assets (%): -31.97344366400462
Buffett classification: The Gruesome
Stock price: 4.36
Shares outstanding: 7327660
Book value: 2816531.165311653
P/B ratio: 11.343243062061003
Market cap (USD): 31948597.6
Debt to equity: 0.0280958337342442
Current ratio: 5.330218068535825
Quick ratio: 5.330218068535825
Buyback yield (%): 0
Retained earnings: -28711653.116531167
Receivables turnover: 0
Capitalized R&D asset: 675609.756097561
ROCI (R&D-adjusted, %): -13.96861844623039
Rule of 40 score: 0
Financial ratios for CMMB — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -667256.6371681415
Net income: -606784.6607669616
Capital expenditures: 0
Net tangible assets: 2861061.9469026546
Owner earnings: -606784.6607669616
Return on net tangible assets (%): -21.208371997113108
Buffett classification: The Gruesome
Stock price: 4.64
Shares outstanding: 7327660
Book value: 2861061.946902655
P/B ratio: 11.883819026291368
Market cap (USD): 34000342.4
Debt to equity: 0
Current ratio: 7.422377622377621
Quick ratio: 7.422377622377621
Buyback yield (%): 0
Retained earnings: -31859292.03539823
Receivables turnover: 0
Capitalized R&D asset: 832304.5542844809
ROCI (R&D-adjusted, %): -17.311104756660683
Rule of 40 score: 0
Financial ratios for CMMB — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -557099.6978851964
Net income: -526283.9879154079
Capital expenditures: 0
Net tangible assets: 3393051.3595166164
Owner earnings: -526283.9879154079
Return on net tangible assets (%): -15.510640192324814
Buffett classification: The Gruesome
Stock price: 2.63
Shares outstanding: 7327660
Book value: 3393051.3595166164
P/B ratio: 5.679768373074525
Market cap (USD): 19271745.8
Debt to equity: 0
Current ratio: 10.489006156552332
Quick ratio: 10.489006156552332
Buyback yield (%): 0
Retained earnings: -33155589.12386707
Receivables turnover: 0
Capitalized R&D asset: 767344.2628509647
ROCI (R&D-adjusted, %): -17.197839174647385
Rule of 40 score: 0
Financial ratios for CMMB — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -620754.716981132
Net income: -588993.7106918239
Capital expenditures: 0
Net tangible assets: 3874213.836477987
Owner earnings: -588993.7106918239
Return on net tangible assets (%): -15.202922077922079
Buffett classification: The Gruesome
Stock price: 1.65
Shares outstanding: 7327660
Book value: 3878616.3522012574
P/B ratio: 3.1172557175287827
Market cap (USD): 12090639
Debt to equity: 0
Current ratio: 9.083220568335589
Quick ratio: 9.083220568335589
Buyback yield (%): 0
Retained earnings: -35100000
Receivables turnover: 0
Capitalized R&D asset: 663314.1193564502
ROCI (R&D-adjusted, %): -13.536967801288805
Rule of 40 score: 0
Financial ratios for CMMB — annual report dated 2025-12-31
Total revenue: 0
Operating income: -3008490.566037736
Net income: -2828616.352201258
Capital expenditures: 943.3962264150942
Operating cash flow: -3500000
Depreciation & amortization: 22012.5786163522
Net tangible assets: 3874213.836477987
Owner earnings: -2807547.1698113205
Return on net tangible assets (%): -72.46753246753246
Buffett classification: The Gruesome
Stock price: 1.65
Shares outstanding: 7327660
Book value: 3878616.3522012574
P/B ratio: 3.1172557175287827
Market cap (USD): 12090639
Debt to equity: 0
Current ratio: 9.083220568335589
Quick ratio: 9.083220568335589
Free cash flow (dilution-adjusted): -3696855.3459119494
Buyback yield (%): 0
Retained earnings: -35100000
Receivables turnover: 0
Capitalized R&D asset: 5589095.491385223
ROCI (R&D-adjusted, %): -47.663153967483396
Rule of 40 score: 0
Financial ratios for DALMIASUG.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.95582223394435
Shares outstanding: 80939303
Market cap (USD): 482060100.4073586
Buyback yield (%): 0
Retained earnings: 258546749.3076619
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DALMIASUG.NS — annual report dated 2023-03-31
Total revenue: 395304506.6991474
Gross profit: 112428745.43239953
Operating income: 45250913.52009744
Net income: 30459196.102314252
Capital expenditures: 26531059.683313034
Operating cash flow: 70992691.83922046
Depreciation & amortization: 14768574.908647992
Net tangible assets: 329460414.1291109
Owner earnings: 18696711.327649213
Return on net tangible assets (%): 5.674949258189859
Capex to operating income (%): 58.63099243627359
Buffett classification: The Good
Stock price: 3.910109622411693
P/E ratio: 10.390344723101531
Shares outstanding: 80939303
Book value: 329470158.34348357
P/B ratio: 0.960577276809553
Market cap (USD): 316481547.4915956
Debt to equity: 0.1678663191556221
Current ratio: 2.7272196034126766
Quick ratio: 0.7067279597958626
Effective tax rate (%): 29.690242935613565
Interest coverage ratio: 10.377374301675976
COGS to revenue (%): 71.55895176323777
SG&A to revenue (%): 2.6634210972284276
Free cash flow (dilution-adjusted): 44461632.15590743
Buyback yield (%): 0
Retained earnings: 265316686.9671133
Inventory turnover: 2.238942233533858
Receivables turnover: 21.787392588614395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.293710651673642
FCF margin (%): 11.24743872190297
Rule of 40 score: 11.24743872190297
Financial ratios for DALMIASUG.NS — annual report dated 2024-03-31
Total revenue: 347607626.81376666
Gross profit: 111839549.10660751
Operating income: 40205060.55882
Net income: 32674181.55654155
Capital expenditures: 43928528.60055163
Operating cash flow: -28697685.57380981
Depreciation & amortization: 15224847.1039693
Net tangible assets: 349375224.84710395
Owner earnings: 3970500.0599592254
Return on net tangible assets (%): 1.1364572464166065
Capex to operating income (%): 109.2611924717392
Buffett classification: The Gruesome
Stock price: 3.9240642994241846
P/E ratio: 9.72055042214177
Shares outstanding: 80939303
Book value: 351620098.3331335
P/B ratio: 0.9032789389122585
Market cap (USD): 317611029.3225768
Debt to equity: 0.48775305576776157
Current ratio: 1.554620273335708
Quick ratio: 0.4466420452060016
Effective tax rate (%): 25.02407748823643
Interest coverage ratio: 6.880155961420069
COGS to revenue (%): 67.8259219650188
SG&A to revenue (%): 1.7097319488046363
Free cash flow (dilution-adjusted): -74866290.92217292
Buyback yield (%): 0
Retained earnings: 289275692.5290802
Inventory turnover: 1.1088820205073828
Receivables turnover: 24.16187380178378
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.412646585680154
FCF margin (%): -21.53758581433056
Revenue growth (%): -12.065857858200738
Rule of 40 score: -33.6034436725313
Financial ratios for DALMIASUG.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 360287864.30960345
Buffett classification: The Gruesome
Stock price: 6.250955566172958
Shares outstanding: 80939303
Book value: 362557333.97037745
P/B ratio: 1.3954978680733232
Market cap (USD): 505947986.61000955
Debt to equity: 0.11966738377705224
Current ratio: 3.484264316227762
Quick ratio: 1.6328340453144432
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DALMIASUG.NS — quarterly report dated 2025-03-31
Total revenue: 118718728.0804302
Gross profit: 40266541.96866962
Operating income: 18639233.10731821
Net income: 23235913.023147065
Capital expenditures: 0
Depreciation & amortization: 4396773.439326631
Net tangible assets: 375800794.9497311
Owner earnings: 27632686.462473698
Return on net tangible assets (%): 7.353014371928079
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.117516629711751
P/E ratio: 3.585709390543247
Shares outstanding: 80939303
Book value: 378129530.0444236
P/B ratio: 0.8813618075811879
Market cap (USD): 333268926.09977823
Debt to equity: 0.3227928718944388
Current ratio: 2.585705499402365
Quick ratio: 0.6630963294767502
Effective tax rate (%): -24.614420062695924
Interest coverage ratio: 9.83590376310919
COGS to revenue (%): 66.0824011343942
Buyback yield (%): 0
Retained earnings: 321776946.4577975
Inventory turnover: 0.40505320593685307
Receivables turnover: 7.691585245777475
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9842867566946216
Rule of 40 score: 0
Financial ratios for DALMIASUG.NS — annual report dated 2025-03-31
Total revenue: 435461772.27028286
Gross profit: 117836100.07014261
Operating income: 40562310.030395135
Net income: 42728548.04769698
Capital expenditures: 16754734.627075052
Operating cash flow: 47912087.91208791
Depreciation & amortization: 15257189.618891746
Net tangible assets: 375800794.9497311
Owner earnings: 41231003.03951367
Return on net tangible assets (%): 10.971505008399177
Capex to operating income (%): 41.30616479810934
Buffett classification: The Good
Stock price: 4.117516629711751
P/E ratio: 7.799678232168271
Shares outstanding: 80939303
Book value: 378129530.0444236
P/B ratio: 0.8813618075811879
Market cap (USD): 333268926.09977823
Debt to equity: 0.3227928718944388
Current ratio: 2.585705499402365
Quick ratio: 0.6630963294767502
Effective tax rate (%): -5.868381415826671
Interest coverage ratio: 5.511834789515489
COGS to revenue (%): 72.93996681825747
SG&A to revenue (%): 1.9471454573764948
Free cash flow (dilution-adjusted): 31157353.285012856
Buyback yield (%): 0
Retained earnings: 321776946.4577975
Inventory turnover: 1.6399198440338731
Receivables turnover: 28.212830417329396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.670521675679458
FCF margin (%): 7.155014577416012
Revenue growth (%): 25.2739406962393
Rule of 40 score: 32.42895527365531